Cargando…

Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories

Plant in vitro cultures represent an attractive and cost-effective alternative to classical approaches to plant secondary metabolite (PSM) production (the “Plant Cell Factory” concept). Among other advantages, they constitute the only sustainable and eco-friendly system to obtain complex chemical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez-Estrada, Karla, Vidal-Limon, Heriberto, Hidalgo, Diego, Moyano, Elisabeth, Golenioswki, Marta, Cusidó, Rosa M., Palazon, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273650/
https://www.ncbi.nlm.nih.gov/pubmed/26848649
http://dx.doi.org/10.3390/molecules21020182
_version_ 1783377436166062080
author Ramirez-Estrada, Karla
Vidal-Limon, Heriberto
Hidalgo, Diego
Moyano, Elisabeth
Golenioswki, Marta
Cusidó, Rosa M.
Palazon, Javier
author_facet Ramirez-Estrada, Karla
Vidal-Limon, Heriberto
Hidalgo, Diego
Moyano, Elisabeth
Golenioswki, Marta
Cusidó, Rosa M.
Palazon, Javier
author_sort Ramirez-Estrada, Karla
collection PubMed
description Plant in vitro cultures represent an attractive and cost-effective alternative to classical approaches to plant secondary metabolite (PSM) production (the “Plant Cell Factory” concept). Among other advantages, they constitute the only sustainable and eco-friendly system to obtain complex chemical structures biosynthesized by rare or endangered plant species that resist domestication. For successful results, the biotechnological production of PSM requires an optimized system, for which elicitation has proved one of the most effective strategies. In plant cell cultures, an elicitor can be defined as a compound introduced in small concentrations to a living system to promote the biosynthesis of the target metabolite. Traditionally, elicitors have been classified in two types, abiotic or biotic, according to their chemical nature and exogenous or endogenous origin, and notably include yeast extract, methyl jasmonate, salicylic acid, vanadyl sulphate and chitosan. In this review, we summarize the enhancing effects of elicitors on the production of high-added value plant compounds such as taxanes, ginsenosides, aryltetralin lignans and other types of polyphenols, focusing particularly on the use of a new generation of elicitors such as coronatine and cyclodextrins.
format Online
Article
Text
id pubmed-6273650
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62736502018-12-28 Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories Ramirez-Estrada, Karla Vidal-Limon, Heriberto Hidalgo, Diego Moyano, Elisabeth Golenioswki, Marta Cusidó, Rosa M. Palazon, Javier Molecules Review Plant in vitro cultures represent an attractive and cost-effective alternative to classical approaches to plant secondary metabolite (PSM) production (the “Plant Cell Factory” concept). Among other advantages, they constitute the only sustainable and eco-friendly system to obtain complex chemical structures biosynthesized by rare or endangered plant species that resist domestication. For successful results, the biotechnological production of PSM requires an optimized system, for which elicitation has proved one of the most effective strategies. In plant cell cultures, an elicitor can be defined as a compound introduced in small concentrations to a living system to promote the biosynthesis of the target metabolite. Traditionally, elicitors have been classified in two types, abiotic or biotic, according to their chemical nature and exogenous or endogenous origin, and notably include yeast extract, methyl jasmonate, salicylic acid, vanadyl sulphate and chitosan. In this review, we summarize the enhancing effects of elicitors on the production of high-added value plant compounds such as taxanes, ginsenosides, aryltetralin lignans and other types of polyphenols, focusing particularly on the use of a new generation of elicitors such as coronatine and cyclodextrins. MDPI 2016-02-03 /pmc/articles/PMC6273650/ /pubmed/26848649 http://dx.doi.org/10.3390/molecules21020182 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ramirez-Estrada, Karla
Vidal-Limon, Heriberto
Hidalgo, Diego
Moyano, Elisabeth
Golenioswki, Marta
Cusidó, Rosa M.
Palazon, Javier
Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories
title Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories
title_full Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories
title_fullStr Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories
title_full_unstemmed Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories
title_short Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories
title_sort elicitation, an effective strategy for the biotechnological production of bioactive high-added value compounds in plant cell factories
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273650/
https://www.ncbi.nlm.nih.gov/pubmed/26848649
http://dx.doi.org/10.3390/molecules21020182
work_keys_str_mv AT ramirezestradakarla elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories
AT vidallimonheriberto elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories
AT hidalgodiego elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories
AT moyanoelisabeth elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories
AT golenioswkimarta elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories
AT cusidorosam elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories
AT palazonjavier elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories